This #GivingTuesday, help us advance health equity
Everyone should benefit from clinical trials. But because some racial and ethnic groups are underrepresented in clinical research, they might benefit less.
Most of today’s medicines and other therapies are based on data obtained primarily from white clinical trial participants. These results don’t necessarily apply to African American and Latino patients. Because they’re not part of the trials, these patients often miss out on opportunities for more effective medicines and better health.
Clinical Research Pathways is trying to change that trend by increasing minority patient participation in clinical trials. And, this #GivingTuesday, we’re asking for your support.
Together, we can help ensure that new medicines work well for all patients, regardless of gender, race, or ethnicity. That will go a long way in advancing health equity, giving all people the same opportunity to live the healthiest life possible.
Your gift will enable us to:
- Continue to partner with Morehouse School of Medicine to train and mentor minority physicians to serve as clinical investigators.
- Partner with other health care systems that serve minority patients.
- Build trust in clinical research among underrepresented minority populations.
- Increase diversity by enrolling more underrepresented minorities in appropriate clinical trials.
- Provide greater access to promising investigational medicines, especially among minority populations.
- Support the development of effective medicines for men and women of all races and ethnicities.
- Open the door to improved health and well-being for all.
It’s a great way to make a difference on #GivingTuesday and every day.
